ROYALTY PHARMA PLC- CL A (RPRX) Stock Analyst Earnings Estimates
NASDAQ:RPRX - Nasdaq - GB00BMVP7Y09 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.237B -2.28% | 2.355B 5.25% | 2.264B -3.86% | 2.928B 29.35% | 3.15B 7.58% | 3.409B 8.22% | 4.504B 32.12% | 4.686B 4.04% | 4.864B 3.80% | 3.549B -27.04% | 3.677B 3.61% | |
| EBITDA YoY % growth | N/A 31.88% | N/A 7.26% | N/A -6.92% | 2.948B 13.47% | 2.936B -0.41% | 3.062B 4.29% | 4.022B 31.35% | 4.368B 8.60% | 4.674B 7.01% | 5.025B 7.51% | 5.471B 8.88% | |
| EBIT YoY % growth | 922.9M -35.49% | 1.492B 61.68% | 1.292B -13.38% | 2.777B 114.86% | 2.988B 7.60% | 2.989B 0.03% | 2.434B -18.57% | 2.57B 5.59% | 2.72B 5.84% | 2.913B 7.10% | 2.994B 2.78% | |
| Operating Margin | 41.25% | 63.37% | 57.10% | 94.84% | 94.86% | 87.68% | 54.04% | 54.84% | 55.92% | 82.08% | 81.43% | |
| EPS YoY % growth | 3.67 64.57% | 4.38 19.35% | 4.10 -6.39% | 4.37 6.57% | 5.11 16.96% | 5.73 12.09% | 8.33 45.48% | 8.65 3.79% | 8.98 3.77% | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 1.11 15.28% | 1.10 8.44% | 1.20 3.95% | 1.33 104.00% |
| Revenue Q2Q % growth | 673.75M 10.81% | 754.72M 33.58% | 781.36M 31.54% | 874.14M 4.19% |
| EBITDA Q2Q % growth | 630.1M 8.14% | 732.01M 11.20% | 737.41M 12.05% | 828.24M 15.43% |
| EBIT Q2Q % growth | 649.23M 140.79% | 774.69M 5.39% | 783.87M 116.83% | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 0.65 -33.67% | 1.62 | -0.97 | -59.90% |
| Q4 2024 Q2Q % growth | 1.15 | 1.08 | 0.07 | 6.88% |
| Q3 2024 Q2Q % growth | 1.01 27.85% | 0.95 | 0.06 | 6.65% |
| Q2 2024 Q2Q % growth | 0.96 14.29% | 0.98 | -0.02 | -2.47% |
| Q1 2024 Q2Q % growth | 0.98 -38.75% | 1.00 | -0.02 | -2.16% |
| Q4 2023 Q2Q % growth | 1.15 -26.28% | 1.03 | 0.12 | 11.63% |
| Q3 2023 Q2Q % growth | 0.79 9.72% | 0.77 | 0.02 | 2.45% |
| Q2 2023 Q2Q % growth | 0.84 6.33% | 0.82 | 0.02 | 1.92% |
| Q1 2023 Q2Q % growth | 1.60 166.67% | 1.30 | 0.30 | 23.19% |
| Q4 2022 Q2Q % growth | 1.56 95.00% | 1.50 | 0.06 | 3.86% |
| Q3 2022 Q2Q % growth | 0.72 323.53% | 0.73 | -0.01 | -1.45% |
| Q2 2022 Q2Q % growth | 0.79 -26.85% | 0.80 | -0.01 | -0.86% |
| Q1 2022 Q2Q % growth | 0.60 233.33% | 0.75 | -0.15 | -19.60% |
| Q4 2021 Q2Q % growth | 0.80 185.71% | 0.79 | 0.01 | 1.20% |
| Q3 2021 Q2Q % growth | 0.17 -64.58% | 0.71 | -0.54 | -75.92% |
| Q2 2021 Q2Q % growth | 1.08 47.95% | 0.71 | 0.37 | 52.35% |
| Q1 2021 Q2Q % growth | 0.18 | 0.66 | -0.48 | -72.85% |
| Q4 2020 Q2Q % growth | 0.28 | 0.71 | -0.43 | -60.46% |
| Q3 2020 Q2Q % growth | 0.48 | 0.60 | -0.12 | -20.46% |
| Q2 2020 Q2Q % growth | 0.73 | 0.62 | 0.11 | 17.60% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 839M 47.71% | 719.45M | 119.55M | 16.62% |
| Q4 2024 Q2Q % growth | 594M -0.34% | 692.47M | -98.47M | -14.22% |
| Q3 2024 Q2Q % growth | 565M 5.35% | 710.02M | -145.02M | -20.42% |
| Q2 2024 Q2Q % growth | 608M 13.01% | 641.1M | -33.1M | -5.16% |
| Q1 2024 Q2Q % growth | 568M -16.96% | 676.48M | -108.48M | -16.04% |
| Q4 2023 Q2Q % growth | 596M 5.36% | 705.48M | -109.48M | -15.52% |
| Q3 2023 Q2Q % growth | 536.313M -6.48% | 630.35M | -94.037M | -14.92% |
| Q2 2023 Q2Q % growth | 538M 0.37% | 547.32M | -9.32M | -1.70% |
| Q1 2023 Q2Q % growth | 684M 21.71% | 869.96M | -185.96M | -21.38% |
| Q4 2022 Q2Q % growth | 565.7M -1.74% | 970.32M | -404.62M | -41.70% |
| Q3 2022 Q2Q % growth | 573.5M -2.10% | 598.92M | -25.42M | -4.24% |
| Q2 2022 Q2Q % growth | 536M -3.42% | 553.02M | -17.02M | -3.08% |
| Q1 2022 Q2Q % growth | 562M -1.92% | 611.75M | -49.75M | -8.13% |
| Q4 2021 Q2Q % growth | 575.7M 0.63% | 567.42M | 8.28M | 1.46% |
| Q3 2021 Q2Q % growth | 585.8M 8.80% | 584.26M | 1.54M | 0.26% |
| Q2 2021 Q2Q % growth | 555M 8.63% | 528.25M | 26.75M | 5.06% |
| Q1 2021 Q2Q % growth | 573M 14.39% | 519.89M | 53.11M | 10.22% |
| Q4 2020 Q2Q % growth | 572.1M 25.05% | 490.33M | 81.77M | 16.68% |
| Q3 2020 Q2Q % growth | 538.4M 15.96% | 462.23M | 76.17M | 16.48% |
| Q2 2020 Q2Q % growth | 510.9M 11.65% | 478.34M | 32.56M | 6.81% |
| Q1 2020 Q2Q % growth | 500.9M 15.18% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.53% | 13.92% | -2.54% | -4.57% |
| Revenue | -0.93% | 1.27% | 0% | -1.48% |